Volume 24, Issue 3, Pages (November 2006)

Slides:



Advertisements
Similar presentations
Volume 50, Issue 6, Pages (June 2013)
Advertisements

Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 55, Issue 1, Pages (July 2014)
Volume 33, Issue 2, Pages (January 2009)
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy  Yongchao Zhao, Xiufang Xiong,
Volume 18, Issue 4, Pages (October 2010)
Damage-Induced Ubiquitylation of Human RNA Polymerase II by the Ubiquitin Ligase Nedd4, but Not Cockayne Syndrome Proteins or BRCA1  Roy Anindya, Ozan.
Volume 16, Issue 1, Pages (October 2004)
Volume 22, Issue 5, Pages (May 2012)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Donghang Cheng, Jocelyn Côté, Salam Shaaban, Mark T. Bedford 
Volume 19, Issue 6, Pages (September 2005)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 63, Issue 6, Pages (September 2016)
Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit
TopBP1 Controls BLM Protein Level to Maintain Genome Stability
Volume 56, Issue 1, Pages (October 2014)
Ras Induces Mediator Complex Exchange on C/EBPβ
The KSHV Immediate-Early Transcription Factor RTA Encodes Ubiquitin E3 Ligase Activity that Targets IRF7 for Proteosome-Mediated Degradation  Yanxing.
Volume 45, Issue 2, Pages (January 2012)
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Volume 54, Issue 3, Pages (May 2014)
Volume 42, Issue 4, Pages (May 2011)
Volume 29, Issue 4, Pages (February 2008)
Volume 18, Issue 5, Pages (January 2017)
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Volume 38, Issue 3, Pages (May 2010)
Volume 13, Issue 1, Pages (January 2008)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
Volume 56, Issue 5, Pages (December 2014)
Volume 124, Issue 2, Pages (January 2006)
c-Src Activates Endonuclease-Mediated mRNA Decay
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 20, Issue 4, Pages (November 2005)
Volume 19, Issue 5, Pages (September 2005)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 26, Issue 6, Pages (June 2007)
Volume 14, Issue 1, Pages (July 2008)
Volume 15, Issue 4, Pages (April 2009)
Cyclin G Recruits PP2A to Dephosphorylate Mdm2
Volume 18, Issue 2, Pages (August 2010)
Volume 26, Issue 1, Pages (April 2007)
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Lindsey A. Allan, Paul R. Clarke  Molecular Cell 
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Volume 122, Issue 1, Pages (July 2005)
Volume 125, Issue 4, Pages (May 2006)
Volume 49, Issue 6, Pages (March 2013)
Volume 33, Issue 5, Pages (November 2010)
Volume 5, Issue 6, Pages (December 2013)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function  Donghua Wen, Jianguo Wu, Lei Wang, Zheng.
Volume 12, Issue 5, Pages (November 2003)
Transcriptional Regulation of AKT Activation by E2F
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 26, Issue 12, Pages e4 (March 2019)
Volume 37, Issue 3, Pages (February 2010)
Volume 22, Issue 3, Pages (May 2006)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 41, Issue 4, Pages (February 2011)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
CDKs Promote DNA Replication Origin Licensing in Human Cells by Protecting Cdc6 from APC/C-Dependent Proteolysis  Niels Mailand, John F.X. Diffley  Cell 
Presentation transcript:

Volume 24, Issue 3, Pages 355-366 (November 2006) Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex  Douglas I. Lin, Olena Barbash, K.G. Suresh Kumar, Jason D. Weber, J. Wade Harper, Andres J.P. Klein-Szanto, Anil Rustgi, Serge Y. Fuchs, J. Alan Diehl  Molecular Cell  Volume 24, Issue 3, Pages 355-366 (November 2006) DOI: 10.1016/j.molcel.2006.09.007 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Identification of αB Crystallin as a Cyclin D1-Associated Protein (A) Silver stain of affinity-purified cyclin D1 complexes prepared from parental NIH 3T3 cells or Flag-D1 3T3 cell lines treated with the proteasome inhibitor LLnL. Cyclin D1-interacting proteins were identified by mass spectrometry. (B) Western blot of endogenous cyclin D1 precipitates prepared from proliferating NIH 3T3 cells treated with DMSO, N-acetyl-leucinyl-leucinyl-methioninal (LLM), or LLnL. Normal rabbit serum (NRS) precipitates served as a negative control. (C) The cyclin D1-αB crystallin interaction is dependent on cyclin D1 phosphorylation at Thr286. NIH 3T3 cells expressing either wild-type cyclin D1 or the D1T286A mutant were treated with vehicle, LLM, or LLnL for 6 hr, and cell lysates prepared from these cells were precipitated with a cyclin D1-specific antibody (13-17G) and probed for cyclin D1 and αB crystallin. Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Phosphorylation-Dependent Interaction between Cyclin D1 and the SCFFBX4-αB Crystallin Complex (A) Endogenous FBX4, cyclin D1, and αB crystallin associate in vivo. Cell lysates prepared from proliferating NIH 3T3 cells treated with DMSO or MG132 were precipitated with antibodies directed against FBX4 or normal rabbit serum (NRS) and subjected to immunoblot with the indicated antibodies. (B) Phospho-T286-dependent binding of cyclin D1 to SCFFBX4-αB crystallin in vitro. Cyclin D1 or phosphorylation-deficient derivatives D1T286A and D1P287A were mixed with SCFFBX4-αB crystallin complexes purified by immunoaffinity chromatography from 293T cells and blotted for cyclin D1; where indicated, FBX4 and αB crystallin were omitted. (C) Cyclin D1-FBX4 binding is dependent on αB crystallin and Thr286 phosphorylation. 293T lysates containing the indicated proteins were incubated with beads coupled to the phosphorylated cyclin D1 peptide or to unphosphorylated cyclin D1 peptide. Bound proteins were detected by immunoblot. (D) Phospho-MYC and -IκKα do not interact with SCFFBX4-αB crystallin. Beads coupled to the indicated peptides were incubated with 293T lysates expressing SCFFBX4-αB crystallin complexes as in (C), and bound FBX4 was detected by immunoblot. (E) Beads coupled to the indicated peptides were incubated with 293T lysates harboring either SCFFBX4-αB crystallin or SCFFBW2 complexes, and bound FBX4 or FBW2 was detected by anti-FLAG western blot. Uncoupled beads served as negative (background) control. Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 The SCFFBX4-αB Crystallin Ubiquitin Ligase Regulates Cyclin D1 Stability and Protein Levels In Vivo (A) NIH 3T3 cells expressing empty vector or (ΔF)FBX4 were pulse labeled with 35S methionine/cysteine and “chased” for the indicated time periods. Cyclin D1 was precipitated and visualized by autoradiography. (B) Western analysis of whole-cell extracts prepared from 293T cells transfected with cyclin D1, CDK4, (ΔF)FBX4, and αB crystallin. (C and D) NIH 3T3 cells expressing either control, αB crystallin (C), or FBX4 shRNAs (D) were treated with 100 μg/mL of cycloheximide for the indicated time periods, and cyclin D1 half-life was determined by western blotting. (E) Expression of FBX4 and αB crystallin promotes cyclin D1 proteolysis. 293T cells were transfected with cyclin D1, CDK4, αB crystallin, FBX4, and GFP. Cell lysates were prepared and immunoblotted for cyclin D1, FBX4, and GFP. (F) Proteasome inhibition inhibits FBX4-dependent cyclin D1 proteolysis. Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 The SCFFBX4-αB Crystallin Complex Catalyzes Cyclin D1 Ubiquitination In Vivo and In Vitro (A) NIH 3T3 cells expressing Flag-cyclin D1 were transfected with HA-ubiquitin, (ΔF)FBX4, and αB crystallin and treated with 20 μM MG132 for 0, 2, and 4 hr. Cell lysates were subjected to precipitation with either normal rabbit serum (NRS) or with a cyclin D1-specific antibody, and ubiquitinated proteins were visualized by anti-HA immunoblot. (B) Same as in (A) except that cyclin D1 immunoprecipitates were probed with a cyclin D1 antibody. (C) Human U2OS cells were cotransfected with HA-tagged ubiquitin, cyclin D1, and shRNAs specific for firefly luciferase or FBX4. Cyclin D1 ubiquitination was detected by immunoprecipitation with an anti-Flag antibody followed by anti-HA western blotting. (D) The SCFFBX4-αB crystallin complex catalyzes ubiquitination of cyclin D1 in vitro. Ubiquitination of in vitro-transcribed and -translated cyclin D1 was assessed by mixing cyclin D1 with GSK3β, ATP, ubiquitin, E1, E2, and a complete SCFFBX4-αB crystallin complex (lane 2). The reactions were also carried out omitting the following: the entire E3 ligase (lane 1); FBX4 (lane 3); Cul1, Skp1, and Roc1 (lane 4); or E1 and E2 (lane 5). (E) The F box of FBX4 and αB crystallin are required for cyclin D1 polyubiquitination in vitro. Ubiquitination reactions were initiated by addition of ATP, ubiquitin, and E1 and E2 enzymes. Where indicated, wild-type FBX4 was replaced with (ΔF)FBX4 (lane 2), and αB crystallin was omitted from the reaction (lane 3). (F) Phosphorylation-deficient cyclin D1T286A is refractory to SCFFBX4-αB crystallin-dependent ubiquitination. Cyclin D1 ubiquitination in (D)–(F) was assessed by autoradiography (upper panels), and input is shown (lower panels). Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Cytoplasmic Localization of FBX4 and αB Crystallin (A) Immunofluorescence of asynchronously growing NIH 3T3 and U2OS cells with N-terminal (top panel) or C-terminal (middle and bottom panels) FBX4-specific antibodies. (B) Immunofluorescence of asynchronously growing mouse fibroblasts stably expressing FBX4-specific hairpins (F-3T3-2, F-3T3-4). (C) Western analysis confirming knockdown of FBX4 in NIH 3T3 cells. Asterisk indicates a nonspecific band detected by the secondary antibody. (D) Stable NIH 3T3 cells expressing empty vector or Flag-tagged FBX4 were fractionated into cytoplasmic (C), nuclear (N), and total (T) extracts. Fractions were used for immunoprecipitation with an anti-Flag antibody or for direct western blots as indicated. Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 The SCFFBX4-αB Crystallin Ubiquitin Ligase Regulates Cell-Cycle Progression (A) Cell-cycle-dependent binding between FBX4 and cyclin D1. NIH 3T3 cells were released from a G0 (serum starvation) block, and binding between cyclin D1 and FBX4 was assessed by IP-western. (B) Lysates prepared from NIH 3T3 cells transfected with GFP or GSK3β kinase-dead (KD) constructs and treated with MG132 were precipitated with FBX4 antiserum or rabbit anti-mouse IgG and subjected to immunoblot with indicated antibodies. (C) Kinetics of cell-cycle reentry from G0 in NIH 3T3 cells expressing shRNAs against FBX4 or αB crystallin. (D) NIH 3T3 cells expressing shRNAs against FBX4 and αB crystallin were released from a nocodazole (G2/M) block in media containing BrdU, and percentage of cells in S phase was assessed by FACS. (E) Immunoblot (cyclin D1) of NIH 3T3 cells expressing shRNAs against FBX4 and αB crystallin released from a nocodazole (G2/M) block for the indicated time. (F) Knockdown of FBX4 and αB crystallin in 3T3 immortalized D1−/− fibroblasts (right panel); control blot of D1 and Skp1 (left panel). (G) D1−/− cells expressing shRNAs against FBX4 and αB crystallin were released from a nocodazole block, and S phase entry was assessed as in (D). Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 7 FBX4 and αB Crystallin Levels Are Altered in Human Cancers (A) Quantification of FBX4 and αB crystallin mRNA levels in a tumor versus matching normal tissue in an mRNA array. (B) Expression of αB crystallin, cyclin D1, and FBX4 in normal human mammary epithelial cells (HMEC), nontumorigenic breast MCF10A cells, and tumorigenic breast cancer cell lines (MCF7, MDA-MB-231, and BT474). (C) MCF10A, MCF7, or MCF7 cells infected with a retrovirus encoding αB crystallin were treated with cycloheximide for the indicated intervals, and levels of cyclin D1, αB crystallin, and actin were assessed by immunoblot. Molecular Cell 2006 24, 355-366DOI: (10.1016/j.molcel.2006.09.007) Copyright © 2006 Elsevier Inc. Terms and Conditions